Canadian court dismisses J&J lawsuit against Boston Scientific

AuntMinnie.com staff writers
May 8, 2008

The Canadian Federal Court has dismissed a lawsuit Johnson & Johnson of New Brunswick, NJ, brought against Boston Scientific, alleging that the company's NIR stent infringed on two of its patents, according to Boston Scientific.

The court found that Natick, MA-based Boston Scientific's NIR stent did not infringe on one of Johnson & Johnson's patents and that the other Johnson & Johnson patent was invalid, Boston Scientific said.

Related Reading

Boston Scientific completes enrollment in MADIT-CRT trial, April 24, 2008

Boston Scientific earns Canadian approval for Taxus, April 17, 2008

Boston Scientific to buy CryoCor, April 16, 2008

Boston Scientific inks deal with Surgi-Vision, April 15, 2008

Boston Scientific loses patent suit, February 13, 2008

Copyright © 2008 AuntMinnie.com

Latest in Interventional
Spine Pain
Minimally invasive spine surgeries reduce long-term opioid use
December 13, 2024
Thyroid 400
RFA successful for treating malignant thyroid nodules
December 13, 2024
Emergency 400
Ultrasound-guided nerve blocks safe for emergency pain management
November 13, 2024
Thyroid Cancer
Thermal ablation effective long term in patients with thyroid cancer
November 7, 2024
Related Stories
187x200 Am Logo
Companies
AuntMinnie.com
2007 12 04 15 42 06 706
Interventional
Vertebral body pattern may indicate risk for cement-related fracture
2007 05 31 15 36 55 706
Interventional
Fibroid arterial perfusion on aortography forecasts incomplete UAE treatment
2006 09 18 13 51 52 706
Interventional
Student-designed CT-guided biopsy device shows early promise
More in Interventional
Minimally invasive spine surgeries reduce long-term opioid use
By Will Morton
Minimally invasive image-guided procedures to treat osteoporotic vertebral fractures appear to be effective for decreasing long-term use of pain medication.
December 13, 2024
Spine Pain
RFA successful for treating malignant thyroid nodules
By Amerigo Allegretto
Radiofrequency ablation (RFA) can successfully treat malignant thyroid nodules with minimal adverse events.
December 13, 2024
Thyroid 400
Ultrasound-guided nerve blocks safe for emergency pain management
By Amerigo Allegretto
Ultrasound-guided nerve blocks (UGNBs) performed by emergency clinicians could be safe for pain management.
November 13, 2024
Emergency 400
Thermal ablation effective long term in patients with thyroid cancer
By Will Morton
Outcomes over 10 years suggest that image-guided thermal ablation is a safe and effective option for patients with papillary thyroid carcinoma.
November 7, 2024
Thyroid Cancer
Mass. radiology provider may be liable for 'unavailable' IR physician
By Kate Madden Yee
The Massachusetts Court of Appeals has ruled that a radiology services provider could be held liable for failing to provide a patient with access to an on-call interventional radiologist.
October 28, 2024
Lawsuit 6511c4190f4c2
GAE could be cost-effective for knee osteoarthritis
By Will Morton
Genicular artery embolization (GAE) is likely a cost-effective treatment for symptomatic knee osteoarthritis.
September 26, 2024
Knee
PAE mitigates enlarged prostate symptoms after 2 years
By Will Morton
Men with enlarged prostates who undergo minimally invasive prostatic artery embolization (PAE) have significant improvements in symptoms after two years.
September 5, 2024
Prostate Imaging
Acute stroke intervention results in long-term benefits
By Will Morton
The benefits of endovascular thrombectomy in patients with acute basilar artery occlusion are sustained at long-term follow-up.
August 26, 2024
Stroke Evt
Should there be an age limit for performing EVT in stroke patients?
By Will Morton
Could a fixed upper age limit be justified for performing endovascular thrombectomies (EVT) to treat the oldest elderly stroke patients?
August 12, 2024
Evt
Cryoneurolysis effective for pain control after rib fractures
By Will Morton
CT-guided cryoneurolysis – the freezing of nerves to alleviate pain – is safe and effective in older adults with rib fractures.
August 7, 2024
I Rs2
Cryoablation safe, effective in treating soft-tissue sarcoma
By Amerigo Allegretto
Percutaneous cryoablation is safe and effective for patients with recurrent or metastatic soft-tissue sarcoma after earlier treatments.
August 1, 2024
(A) Axial noncontrast CT chest image shows soft tissue mass in the anterior chest wall (arrow). The lesion was treated by percutaneous cryoablation. (B) Intraprocedural axial CT image obtained during cryoablation. The pink outline represents the target lesion and the blue outline represents ice ball. Based on review, the procedure was classified as achieving adequate ablation. (C) Axial contrast-enhanced CT chest image, obtained three months after ablation (patient’s first follow-up exam), shows involution of the target lesion without evidence of residue. Image courtesy of the ARRS.
A few interventional radiologists get lion's share of industry payments
By Erik L. Ridley
A very small percentage of interventional radiologists are benefitting the most from industry payments.
July 24, 2024
Dollars Pile
Page 1 of 181
Next Page